During the past decade, Hong Myeong-Ki conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hong Myeong-Ki" are "Coronary Artery Disease" (1 trials), "Drug-eluting Stent (DES)" (1 trials), "Ischemic Heart Disease" (1 trials), "Myocardial Infarction" (1 trials) and "Stent Stenosis" (1 trials). Many other conditions were trialed in "Hong Myeong-Ki" in a lesser frequency.

Most popular intervention types in "Hong Myeong-Ki" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "1st-generation drug-eluting stent" (1 trials), "2nd-generation drug-eluting stents" (1 trials), "Atorvastatin (High dose statin treatment)" (1 trials) and "Pravastatin (High dose statin treatment)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hong Myeong-Ki" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hong Myeong-Ki". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hong Myeong-Ki, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hong Myeong-Ki, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".